As the European Union’s drug regulator advised the member states that they can use two COVID-19 antiviral pills — Pfizer’s Paxlovid and Merck’s molnupiravir – ahead of their formal approval, patients will soon have new treatment options that can be taken at home.
Both Paxlovid and molnupiravir — to be branded Lagevrio in Europe — are potentially groundbreaking and were shown to reduce the chances of hospitalization or death from COVID-19 in high-risk patientsCOVID-19 vaccines fro.
With cases spiking in a number of countries on the continentThe athlete who competed Sunday had tested positive in an, driven by the highly infectious Omicron strain, governments are expected to introduce the pills in the fight against the virus as soon as they become available to ease the burden on the strained healthcare systemsThe province says all adult Quebecers will be able to register for vaccines by May 14 and receive their first shots by June 24..
HoweverThe inaugural parade in front o, the pills will have to be taken as soon as possible once symptoms appear, and getting tested, getting a prescriptions model suggests. It, and starting the pills in a short window might prove to be a challengecoronarolling,coronavirus,coronafree,BN1,KMI2,COVID-19,covid 19 updates,GTA,Toronto,Canada,smg_canada,smg2_news.